Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study

The optimal therapy for patients with non-metastatic biochemically relapsed prostate cancer (BRPC-M0) after local therapy is elusive. Thus, the evaluation of new non-toxic compounds in BRPC-M0 patients is warranted. PectaSol(®)-Modified citrus pectin (P-MCP) is a food supplement categorized as GRAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Keizman, Daniel, Frenkel, Moshe, Peer, Avivit, Rosenbaum, Eli, Sarid, David, Leibovitch, Ilan, Mano, Roy, Yossepowitch, Ofer, Wolf, Ido, Geva, Ravit, Margel, David, Rouvinov, Keren, Stern, Anat, Dresler, Hadas, Kushnir, Igal, Eliaz, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459199/
https://www.ncbi.nlm.nih.gov/pubmed/37630724
http://dx.doi.org/10.3390/nu15163533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459199/
https://www.ncbi.nlm.nih.gov/pubmed/37630724
http://dx.doi.org/10.3390/nu15163533

Ejemplares similares